Supplementary Figure S2. Omit maps (F o --F c ) for ligands within CNPcat mutant structures. (A)
The electron density in the active site of T232A fits to a 2ʹ′--AMP product, indicating residual catalytic activity for this mutant. (B) The density within the active site of R307Q fits a 2ʹ′--AMP product in a mixed conformation. (C) Omit maps for V321A crystallized with 2ʹ′,5ʹ′--ADP in two different space groups. (D) The extra densities for active site--bound 2ʹ′--AMP in P225G and P296G reveal differences in ligand occupancy: in P225G, the product has a lower occupancy than for P296G. All omit maps are contoured at 3σ, with the exception of P225G contoured at 2σ. Figure S3 . CNPcat thermal stability in the presence of ligands. All T m values were obtained based on the midpoint of rapid elevation of SYPRO Orange fluorescence as a function of temperature. Error margins have been calculated from triplicate values. The structures of the used ligands are shown below to clarify their differences. (1420) 7167 (707) 13840 (1359) 18374 (1795) 29128 (2885) 5828 (559) 17983 (1307) 27315 (1991) 12659 (1238) 13867 (1349) 16409 (1523) 13871 (1034) 13665 (991) 14961 (1205) 10929 (1044) 90347 (6610) Multiplicity 6.0 (5.9) 3.6 (3.6) 3.2 (2.9) 6.4 (4.2) 6.9 (6.2) 4.4 (4.1) 6.9 (7.0) 7.1 (6.8) 5.7 (5.6) 3.3 (3.2) 3.6 (3.1) 3.6 (3.6) 6.6 (6.7) 2.9 (1.9) 3.6 (3.1) 3.7 (2.9) * R307 is a trypsination site, and therefore, the peptides covering the mutation are absent. The desired mutation is visible in the crystal structure (PDB ID 4wdb) ** The peptide covering the mutation was absent from this mass spectrum. The desired mutation is visible in the crystal structure (PDB ID 4wc9) *** This mutation resides in a disordered loop and is not visible in the crystal structure (PDB ID 4wda)
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